Regulatory T Cell Suppressive Activity Predicts Disease Relapse During Disease-Modifying Anti-rheumatic Drug Dose Reduction in Rheumatoid Arthritis: A Prospective Cohort Study

When the dose of conventional disease-modifying anti-rheumatic drugs (cDMARDs) is tapered in rheumatoid arthritis (RA) patients who achieve sustained remission, biomarkers for predicting disease relapse may be needed. A prospective, unblinded cohort study was conducted in nine RA patients with remis...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanjana, Korawit, Chevaisrakul, Parawee, Matangkasombut, Ponpan, Paisooksantivatana, Karan, Lumjiaktase, Putthapoom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011614/
https://www.ncbi.nlm.nih.gov/pubmed/32118010
http://dx.doi.org/10.3389/fmed.2020.00025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011614/
https://www.ncbi.nlm.nih.gov/pubmed/32118010
http://dx.doi.org/10.3389/fmed.2020.00025

Ejemplares similares